The Last Man Woman Standing: Why Protecting and Improving Access to Abortion Medication is Necessary Post-Dobbs
Jordan Jekel
ABSTRACT
To ensure that abortion access remains available for many American women in our post-Roe society, it is imperative that lawmakers and regulators protect and improve access to mifepristone, the “abortion pill.” Greater access to mifepristone may improve women’s health and increase abortion access for marginalized communities. However, contrasting state laws regarding prosecution and prescription of the drug and an overly stringent Risk Evaluation and Mitigation Strategy (REMS) continue to create barriers to access and stifle these potential benefits. This Article outlines proposed solutions to protect and improve medication abortion access and addresses the impending legal battles and attacks against mifepristone.
Food and Drug Law Journal
Volume 78, Number 4